Homepage

Read about the Oxford Vaccine Centre’s COVID-19 vaccine trial.

Com-COV3: Vaccine study to research third dose booster options for 12-to-15 year-olds –find your closest study site and read the press release

Recruiting Now: A PHASE 2B, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF BPZE1 INTRANASAL PERTUSSIS VACCINE IN HEALTHY ADULTS TO ASSESS PROTECTION AGAINST COLONIZATION FOLLOWING CHALLENGE WITH VIRULENT WILD-TYPE BORDETELLA PERTUSSIS (CHAMPION-1 STUDY)

If you are aged 18 to 55 years old, in good health and live in the Oxford area, then you may be eligible to take part.

New survey launched to explore the acceptability of the Gonococcal Controlled Human Infection Model in UK men.

Researchers at the University of Oxford have launched a new mixed methods study to explore the acceptability of the Gonococcal Controlled Human Infection Model (GC-CHIM) in UK men.

Oxford Ebola vaccine manufactured and shipped in record time by SII

From running COVID-19 trials to researching respiratory diseases - Daniela Ferreira discusses her journey from Brazil to Oxford

It’s not just Covid: the triple threat that could overwhelm the NHS this winter - Andrew Pollard

Take part in a clinical trial – see a list of all the trials we are currently recruiting to.

Child being vaccinated

Non-COVID research statement

The Oxford Vaccine Group will be continuing with some of our non-COVID research, particularly our paediatric studies, during the COVID-19 pandemic. This is because as part of these studies we give babies their routine primary immunisations on behalf of their GPs. This reduces the administrative burden on the NHS, allowing them to free up capacity and prioritise their workload to be focused on doing what is necessary to manage the response to the COVID-19 pandemic. The participants also benefit from having the vaccines in the safety of their homes or a convenient location.

Vaccine Knowledge

The Vaccine Knowledge Project aims to be a source of independent information about vaccines and infectious diseases.

See more

Research

Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.

Explore

Events and Training

We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.

Learn

Get involved

There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.

Participate

Latest publications

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.
Journal article

Green C. et al, (2023), Clin Exp Immunol
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials
Journal article

EWER K., (2023), Clinical and Experimental Immunology
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa.
Journal article

McMahon WC. et al, (2023), AIDS, 37, 105 - 112
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine.
Journal article

Rajan M. et al, (2023), Pediatr Infect Dis J, 42, 66 - 73
ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys.
Journal article

van Doremalen N. et al, (2022), NPJ Vaccines, 7

Upcoming events

18th Annual OVG Immunisation Seminar

Thursday, 16 March 2023, 9am to 4pm @ Kassam Stadium Events & Conference Centre

A one-day seminar targeted at HCPs providing key updates and the latest news on the topic of immunisations.

Introduction to Immunisation Training – face-to-face event

Tuesday, 28 March 2023 to Wednesday, 29 March 2023, 9am - 4pm @ Holiday Inn Reading West Bath Road, Padworth, RG7 5HT

A free 2-day face-to-face training for HCPs working within the BOB (Buckinghamshire, Oxfordshire and Berkshire West) Integrated Care System who are new to the role of administering, promoting and/or advising about vaccines.

Immunisation Update Training – Virtual

Tuesday, 20 June 2023, 2pm to 5pm

A free half-day training delivered via Microsoft Teams for HCPs working within the BOB (Buckinghamshire, Oxfordshire & Berkshire West) Integrated Care System who already administer, promote and/or advise about vaccines.

National Immunisation Schedule Evaluation Consortium

OVG is part of the National Immunisation Schedule Evaluation Consortium; a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency, with a brief of conducting clinical research relevant to UK immunisation policy

More about NISEC

We’ve made a vaccine, now you can make the difference

We’ve heard about how effective vaccines are, but what do we need for them to have the biggest impact on the coronavirus pandemic?

How to make a vaccine in record time

Vaccines usually take decades to develop – so how is Oxford University's ChAdOx1 nCoV-1 vaccine trial moving so quickly? It comes down to careful planning, extraordinary logistics and a whole lot of help from partners around the world.

Cookies on this website